Lista de obras -

Acceptance of Inflammatory Bowel Disease Treatment Recommendations Based on Appropriateness Ratings: do Practicing Gastroenterologists Agree with Experts?

scientific article published on 01 February 2015

Addressing current treatment challenges in Crohn's disease in real life: a physician's survey

artículo científico publicado en 2014

Age, smoking and overweight contribute to the development of intestinal metaplasia of the cardia

artículo científico publicado en 2012

Anti-TNF Treatment for Extraintestinal Manifestations of Inflammatory Bowel Disease in the Swiss IBD Cohort Study

artículo científico publicado en 2017

Appropriate maintenance treatment for Crohn's disease: Results of a multidisciplinary international expert panel - EPACT II.

artículo científico publicado en 2009

Appropriate management of special situations in Crohn's disease (upper gastro-intestinal; extra-intestinal manifestations; drug safety during pregnancy and breastfeeding): Results of a multidisciplinary international expert panel-EPACT II.

artículo científico publicado en 2009

Appropriate therapy for fistulizing and fibrostenotic Crohn's disease: Results of a multidisciplinary expert panel — EPACT II

article

Appropriateness and long-term discontinuation rate of biological therapies in ulcerative colitis

artículo científico publicado en 2014

Appropriateness of early management of newly diagnosed Crohn's disease in a European population-based cohort

artículo científico publicado en 2010

Appropriateness of therapy for active Crohn's disease: Results of a multidisciplinary international expert panel-EPACT II.

artículo científico publicado en 2009

Best practice in the management of mild-to-moderately active ulcerative colitis and achieving maintenance of remission using mesalazine ⬇️

artículo científico publicado el 1 de agosto de 2010

Changes in Biosimilar Knowledge among European Crohn's Colitis Organization [ECCO] Members: An Updated Survey.

artículo científico publicado en 2016

Characteristics of non-responders to self-reported questionnaires in a large inflammatory bowel disease cohort study

artículo científico publicado en 2015

Chronological Order of Appearance of Extraintestinal Manifestations Relative to the Time of IBD Diagnosis in the Swiss Inflammatory Bowel Disease Cohort

artículo científico publicado en 2015

Clinical experience with adalimumab in a multicenter Swiss cohort of patients with Crohn's disease

scientific article published on 12 January 2010

Cohort Profile Update: The Swiss Inflammatory Bowel Disease Cohort Study (SIBDCS)

scientific article published on 01 April 2019

Cohort Profile: The Swiss Eosinophilic Esophagitis Cohort Study (SEECS)

scientific article published on 31 January 2018

Cohort profile: the Swiss Inflammatory Bowel Disease Cohort Study (SIBDCS).

artículo científico publicado en 2008

Comment on "Resistin-like molecule beta (RELMbeta/FIZZ2) is highly expressed in the ileum of SAMP1/YitFc mice and is associated with initiation of ileitis"

artículo científico publicado en 2008

Cost analysis of long-term treatment of patients with symptomatic gastroesophageal reflux disease (GERD) with esomeprazole on-demand treatment or esomeprazole continuous treatment: an open, randomized, multicenter study in Switzerland

artículo científico publicado en 2008

Critical role of the GM-CSF signaling pathway in macrophage pro-repair activities

artículo científico publicado en 2014

Development of the Crohn's disease digestive damage score, the Lémann score

artículo científico publicado en 2010

Diagnostic delay in Crohn's disease is associated with a complicated disease course and increased operation rate

artículo científico publicado en 2013

Differences in Outcomes Reported by Patients With Inflammatory Bowel Diseases vs Their Health Care Professionals

scientific article published on 22 November 2018

Drug safety in Crohn's disease therapy.

artículo científico publicado en 2007

Drug safety in the treatment of Crohn's disease

artículo científico publicado en 2005

EMA response to ECCO position statement on biosimilars

artículo científico publicado en 2014

EPACT II: project and methods.

artículo científico publicado en 2007

Efficacy and safety of certolizumab pegol in an unselected crohn's disease population: 26-week data of the FACTS II survey

artículo científico publicado en 2010

Efficacy and safety of certolizumab pegol induction therapy in an unselected Crohn's disease population: results of the FACTS survey

artículo científico publicado en 2010

Efficacy, Safety and Mucosal Healing of Methotrexate in a Large Longitudinal Cohort of Inflammatory Bowel Disease Patients

artículo científico publicado en 2017

Endoscopic interventions for preneoplastic and neoplastic lesions: mucosectomy, argon plasma coagulation, and photodynamic therapy

artículo científico publicado en 2002

Engineered lymphocytes to treat dinitrobenzene sulphonic acid colitis in mice

artículo científico publicado en 2003

European evidence-based Consensus on the management of ulcerative colitis: Special situations

scientific article published on 28 January 2008

Evaluating Appropriateness of Treatment for Crohn’s Disease: Feasibility of an Explicit Approach

article

Experts Opinion on the Practical Use of Azathioprine and 6-Mercaptopurine in Inflammatory Bowel Disease

artículo científico publicado en 2016

Extraintestinal Manifestations of Crohn’s Disease

article

Extraintestinal manifestations of Crohn's disease

artículo científico publicado en 2005

Factors influencing the outcome of vedolizumab treatment: Real-life data with objective outcome measurements

artículo científico publicado en 2020

Fibrostenotic Crohn's disease.

scientific article published on January 2007

Fistulizing Crohn's disease

artículo científico publicado en 2005

Fistulizing Crohn’s Disease

article

Frequency and type of drug-related side effects necessitating treatment discontinuation in the Swiss Inflammatory Bowel Disease Cohort

artículo científico publicado en 2018

Granulocyte-macrophage colony-stimulating factor elicits bone marrow-derived cells that promote efficient colonic mucosal healing

artículo científico publicado en 2010

Health care resource utilization and costs of NSAID-induced gastrointestinal toxicity. A population-based study in Switzerland

artículo científico publicado en 2004

High Immunogenicity of the Pneumococcal Conjugated Vaccine in Immunocompromised Adults With Inflammatory Bowel Disease

artículo científico publicado en 2019

Immunology of Helicobacter pylori infection

scientific article published on 01 January 2006

Impact of Treatment-Related Beliefs on Medication Adherence in Immune-Mediated Inflammatory Diseases: Results of the Global ALIGN Study

artículo científico publicado en 2016

Inflammatory Articular Disease in Patients with Inflammatory Bowel Disease: Result of the Swiss IBD Cohort Study

artículo científico publicado en 2015

Inflammatory gene profiles in gastric mucosa during Helicobacter pylori infection in humans

artículo científico

Infliximab for Crohnʼs disease in the Swiss IBD Cohort Study

artículo científico publicado en 2010

Infliximab for the treatment of disseminated pyoderma gangrenosum associated with ulcerative colitis. Case report and literature review

artículo científico publicado en 2007

Information Needs and Concerns of Patients with Inflammatory Bowel Disease: What Can We Learn from Participants in a Bilingual Clinical Cohort?

artículo científico publicado en 2016

Interleukin-17 is a critical mediator of vaccine-induced reduction of Helicobacter infection in the mouse model

artículo científico publicado en 2009

Liver transplantation: new organ allocation system in Switzerland

artículo científico publicado en 2008

Long-Term Effiicacy and Safety of Certolizumab Pegol in an Unselected Crohn's Disease Population: The FACTS III Survey

artículo científico publicado en 2017

Long-term efficacy and safety of ustekinumab in 122 refractory Crohn's disease patients: a multicentre experience.

artículo científico publicado en 2018

Maintenance of medically induced remission of Crohn's disease.

artículo científico publicado en 2007

Maintenance of remission in Crohn's disease

artículo científico publicado en 2005

Maintenance of surgically induced remission of Crohn's disease

artículo científico publicado en 2007

Management of ulcerative colitis in 2017

artículo científico publicado en 2017

Mast cells are critical mediators of vaccine-induced Helicobacter clearance in the mouse model

artículo científico publicado en 2005

Methotrexate Is Not Superior to Placebo for Inducing Steroid-Free Remission, but Induces Steroid-Free Clinical Remission in a Larger Proportion of Patients With Ulcerative Colitis

artículo científico publicado en 2015

Microbial network disturbances in relapsing refractory Crohn's disease

scientific article published on 21 January 2019

Mild-to-moderate active luminal Crohn's disease.

artículo científico publicado en 2007

Monitoring disease activity and progression in Crohn's disease. A Swiss perspective on the IBD ahead 'optimised monitoring' recommendations

artículo científico publicado en 2014

Negative Screening Does Not Rule Out the Risk of Tuberculosis in Patients with Inflammatory Bowel Disease Undergoing Anti-TNF Treatment: A Descriptive Study on the GETAID Cohort

artículo científico publicado en 2016

Obstructive fibrostenotic Crohn's disease

artículo científico publicado en 2005

PAR2 Promotes Vaccine-Induced Protection Against Helicobacter Infection in Mice ⬇️

artículo científico publicado el 23 de junio de 2011

Patient self-reported concerns in inflammatory bowel diseases: A gender-specific subjective quality-of-life indicator

artículo científico publicado en 2017

Patient-reported healthcare expectations in inflammatory bowel diseases.

artículo científico publicado en 2018

Patients and gastroenterologists' perceptions of treatments for inflammatory bowel diseases: do their perspectives match?

artículo científico publicado en 2016

Patients' information-seeking activity is associated with treatment compliance in inflammatory bowel disease patients

article

Penetrating or Stricturing Diseases are the Major Determinants of Time to First and Repeat Resection Surgery in Crohn's Disease

article

Position statement on the use of biosimilars in inflammatory bowel disease

scientific article published on 02 December 2019

Pregnancy and Crohn's disease

artículo científico publicado en 2005

Pregnancy and breastfeeding in patients with Crohn's disease

artículo científico publicado en 2007

Prevalence of Inflammatory Bowel Disease in the Canton of Vaud (Switzerland): A population-based cohort study

artículo científico publicado en 2007

Publisher Correction: Microbial network disturbances in relapsing refractory Crohn's disease

artículo científico publicado en 2019

Recommendations for the treatment of Crohn's disease with tumor necrosis factor antagonists: an expert consensus report

artículo científico publicado en 2011

Recommendations for the treatment of ulcerative colitis with infliximab: a gastroenterology expert group consensus

artículo científico publicado en 2012

Recurrent Acute Pancreatitis and Therapy for Ulcerative Colitis

artículo científico publicado en 2010

Reduction of Helicobacter infection in IL-10-/- mice is dependent on CD4+ T cells but not on mast cells

artículo científico publicado en 2008

Severe and steroid-resistant Crohn's disease

artículo científico publicado en 2007

Severe and steroid-resistant Crohn's disease.

artículo científico publicado en 2005

Structural Basis of Bone Fragility in Young Subjects with Inflammatory Bowel Disease: A High-resolution pQCT Study of the SWISS IBD Cohort (SIBDC).

artículo científico publicado en 2017

Subcutaneous Ustekinumab Provides Clinical Benefit for Two-Thirds of Patients With Crohn's Disease Refractory to Anti-Tumor Necrosis Factor Agents.

artículo científico publicado en 2015

Systematic evaluation of risk factors for diagnostic delay in inflammatory bowel disease

artículo científico publicado en 2011

TNF-Alpha Blockers in Inflammatory Bowel Diseases: Practical Recommendations and a User's Guide: An Update

artículo científico publicado en 2020

Tegaserod is safe, well tolerated and effective in the treatment of patients with non-diarrhoea irritable bowel syndrome

artículo científico publicado en 2005

The Positioning of Colectomy in the Treatment of Ulcerative Colitis in the Era of Biologic Therapy ⬇️

artículo científico publicado el 1 de noviembre de 2013

The Relevance of Vitamin and Iron Deficiency in Patients with Inflammatory Bowel Diseases in Patients of the Swiss IBD Cohort

article

Therapeutic Drug Monitoring to Guide Clinical Decision Making in Inflammatory Bowel Disease Patients with Loss of Response to Anti-TNF: A Delphi Technique-Based Consensus

scientific article published on 28 August 2019

Therapy of mild to moderate luminal Crohn's disease

artículo científico publicado en 2005

Toll-interacting protein modulates colitis susceptibility in mice.

artículo científico publicado en 2014

Treatment Algorithms for Crohn's Disease

scientific article published on 13 March 2020

Treatment algorithm for moderate to severe ulcerative colitis

artículo científico publicado en 2011

Treatment of gastroduodenal Crohn's disease

artículo científico publicado en 2005

Treatment of postoperative Crohn's disease

artículo científico publicado en 2005

Upper gastrointestinal Crohn's disease.

artículo científico publicado en 2007

Varicella zoster virus in inflammatory bowel disease patients: what every gastroenterologist should know

artículo científico publicado en 2020

Vedolizumab in refractory microscopic colitis: an international case series

scientific article published on 01 March 2019

Viewpoint: Knowledge and viewpoints on biosimilar monoclonal antibodies among members of the European Crohn's and Colitis Organization

artículo científico publicado en 2014

When do we dare to stop biological or immunomodulatory therapy for Crohn's disease? Results of a multidisciplinary European expert panel

artículo científico publicado en 2013

Wireless capsule pH monitoring: does it fulfil all expectations?

artículo científico publicado en 2007

[De novo inflammatory bowel diseases after liver transplantation: description of four new cases and a review of the literature]

artículo científico publicado en 2006

[Intestinal inflammatory diseases]

[Main therapeutic advances in IBD in 2007]

artículo científico publicado en 2008

Lista de obras de

Acceptance of Inflammatory Bowel Disease Treatment Recommendations Based on Appropriateness Ratings: do Practicing Gastroenterologists Agree with Experts?

Addressing current treatment challenges in Crohn's disease in real life: a physician's survey

Age, smoking and overweight contribute to the development of intestinal metaplasia of the cardia

Anti-TNF Treatment for Extraintestinal Manifestations of Inflammatory Bowel Disease in the Swiss IBD Cohort Study

Appropriate maintenance treatment for Crohn's disease: Results of a multidisciplinary international expert panel - EPACT II.

Appropriate management of special situations in Crohn's disease (upper gastro-intestinal; extra-intestinal manifestations; drug safety during pregnancy and breastfeeding): Results of a multidisciplinary international expert panel-EPACT II.

Appropriate therapy for fistulizing and fibrostenotic Crohn's disease: Results of a multidisciplinary expert panel — EPACT II

Appropriateness and long-term discontinuation rate of biological therapies in ulcerative colitis

Appropriateness of early management of newly diagnosed Crohn's disease in a European population-based cohort

Appropriateness of therapy for active Crohn's disease: Results of a multidisciplinary international expert panel-EPACT II.

Best practice in the management of mild-to-moderately active ulcerative colitis and achieving maintenance of remission using mesalazine ⬇️

Changes in Biosimilar Knowledge among European Crohn's Colitis Organization [ECCO] Members: An Updated Survey.

Characteristics of non-responders to self-reported questionnaires in a large inflammatory bowel disease cohort study

Chronological Order of Appearance of Extraintestinal Manifestations Relative to the Time of IBD Diagnosis in the Swiss Inflammatory Bowel Disease Cohort

Clinical experience with adalimumab in a multicenter Swiss cohort of patients with Crohn's disease

Cohort Profile Update: The Swiss Inflammatory Bowel Disease Cohort Study (SIBDCS)

Cohort Profile: The Swiss Eosinophilic Esophagitis Cohort Study (SEECS)

Cohort profile: the Swiss Inflammatory Bowel Disease Cohort Study (SIBDCS).

Comment on "Resistin-like molecule beta (RELMbeta/FIZZ2) is highly expressed in the ileum of SAMP1/YitFc mice and is associated with initiation of ileitis"

Cost analysis of long-term treatment of patients with symptomatic gastroesophageal reflux disease (GERD) with esomeprazole on-demand treatment or esomeprazole continuous treatment: an open, randomized, multicenter study in Switzerland

Critical role of the GM-CSF signaling pathway in macrophage pro-repair activities

Development of the Crohn's disease digestive damage score, the Lémann score

Diagnostic delay in Crohn's disease is associated with a complicated disease course and increased operation rate

Differences in Outcomes Reported by Patients With Inflammatory Bowel Diseases vs Their Health Care Professionals

Drug safety in Crohn's disease therapy.

Drug safety in the treatment of Crohn's disease

EMA response to ECCO position statement on biosimilars

EPACT II: project and methods.

Efficacy and safety of certolizumab pegol in an unselected crohn's disease population: 26-week data of the FACTS II survey

Efficacy and safety of certolizumab pegol induction therapy in an unselected Crohn's disease population: results of the FACTS survey

Efficacy, Safety and Mucosal Healing of Methotrexate in a Large Longitudinal Cohort of Inflammatory Bowel Disease Patients

Endoscopic interventions for preneoplastic and neoplastic lesions: mucosectomy, argon plasma coagulation, and photodynamic therapy

Engineered lymphocytes to treat dinitrobenzene sulphonic acid colitis in mice

European evidence-based Consensus on the management of ulcerative colitis: Special situations

Evaluating Appropriateness of Treatment for Crohn’s Disease: Feasibility of an Explicit Approach

Experts Opinion on the Practical Use of Azathioprine and 6-Mercaptopurine in Inflammatory Bowel Disease

Extraintestinal Manifestations of Crohn’s Disease

Extraintestinal manifestations of Crohn's disease

Factors influencing the outcome of vedolizumab treatment: Real-life data with objective outcome measurements

Fibrostenotic Crohn's disease.

Fistulizing Crohn's disease

Fistulizing Crohn’s Disease

Frequency and type of drug-related side effects necessitating treatment discontinuation in the Swiss Inflammatory Bowel Disease Cohort

Granulocyte-macrophage colony-stimulating factor elicits bone marrow-derived cells that promote efficient colonic mucosal healing

Health care resource utilization and costs of NSAID-induced gastrointestinal toxicity. A population-based study in Switzerland

High Immunogenicity of the Pneumococcal Conjugated Vaccine in Immunocompromised Adults With Inflammatory Bowel Disease

Immunology of Helicobacter pylori infection

Impact of Treatment-Related Beliefs on Medication Adherence in Immune-Mediated Inflammatory Diseases: Results of the Global ALIGN Study

Inflammatory Articular Disease in Patients with Inflammatory Bowel Disease: Result of the Swiss IBD Cohort Study

Inflammatory gene profiles in gastric mucosa during Helicobacter pylori infection in humans

Infliximab for Crohnʼs disease in the Swiss IBD Cohort Study

Infliximab for the treatment of disseminated pyoderma gangrenosum associated with ulcerative colitis. Case report and literature review

Information Needs and Concerns of Patients with Inflammatory Bowel Disease: What Can We Learn from Participants in a Bilingual Clinical Cohort?

Interleukin-17 is a critical mediator of vaccine-induced reduction of Helicobacter infection in the mouse model

Liver transplantation: new organ allocation system in Switzerland

Long-Term Effiicacy and Safety of Certolizumab Pegol in an Unselected Crohn's Disease Population: The FACTS III Survey

Long-term efficacy and safety of ustekinumab in 122 refractory Crohn's disease patients: a multicentre experience.

Maintenance of medically induced remission of Crohn's disease.

Maintenance of remission in Crohn's disease

Maintenance of surgically induced remission of Crohn's disease

Management of ulcerative colitis in 2017

Mast cells are critical mediators of vaccine-induced Helicobacter clearance in the mouse model

Methotrexate Is Not Superior to Placebo for Inducing Steroid-Free Remission, but Induces Steroid-Free Clinical Remission in a Larger Proportion of Patients With Ulcerative Colitis

Microbial network disturbances in relapsing refractory Crohn's disease

Mild-to-moderate active luminal Crohn's disease.

Monitoring disease activity and progression in Crohn's disease. A Swiss perspective on the IBD ahead 'optimised monitoring' recommendations

Negative Screening Does Not Rule Out the Risk of Tuberculosis in Patients with Inflammatory Bowel Disease Undergoing Anti-TNF Treatment: A Descriptive Study on the GETAID Cohort

Obstructive fibrostenotic Crohn's disease

PAR2 Promotes Vaccine-Induced Protection Against Helicobacter Infection in Mice ⬇️

Patient self-reported concerns in inflammatory bowel diseases: A gender-specific subjective quality-of-life indicator

Patient-reported healthcare expectations in inflammatory bowel diseases.

Patients and gastroenterologists' perceptions of treatments for inflammatory bowel diseases: do their perspectives match?

Patients' information-seeking activity is associated with treatment compliance in inflammatory bowel disease patients

Penetrating or Stricturing Diseases are the Major Determinants of Time to First and Repeat Resection Surgery in Crohn's Disease

Position statement on the use of biosimilars in inflammatory bowel disease

Pregnancy and Crohn's disease

Pregnancy and breastfeeding in patients with Crohn's disease

Prevalence of Inflammatory Bowel Disease in the Canton of Vaud (Switzerland): A population-based cohort study

Publisher Correction: Microbial network disturbances in relapsing refractory Crohn's disease